Drug Shortage Report for APO-COLESEVELAM
| Report ID | 173826 |
| Drug Identification Number | 02494051 |
| Brand name | APO-COLESEVELAM |
| Common or Proper name | COLESEVELAM |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | COLESEVELAM HYDROCHLORIDE |
| Strength(s) | 625MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 180 BTL |
| ATC code | C10AC |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-11-01 |
| Estimated end date | 2023-02-10 |
| Actual end date | 2023-02-08 |
| Shortage status | Resolved |
| Updated date | 2023-02-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v16 | 2023-02-09 | French | Compare |
| v15 | 2023-02-09 | English | Compare |
| v14 | 2023-01-26 | French | Compare |
| v13 | 2023-01-26 | English | Compare |
| v12 | 2023-01-20 | French | Compare |
| v11 | 2023-01-20 | English | Compare |
| v10 | 2023-01-06 | French | Compare |
| v9 | 2023-01-06 | English | Compare |
| v8 | 2022-12-23 | French | Compare |
| v7 | 2022-12-23 | English | Compare |
| v6 | 2022-12-16 | French | Compare |
| v5 | 2022-12-16 | English | Compare |
| v4 | 2022-12-09 | French | Compare |
| v3 | 2022-12-09 | English | Compare |
| v2 | 2022-11-04 | French | Compare |
| v1 | 2022-11-04 | English | Compare |
Showing 1 to 16 of 16